Find Your Local Office
Research Summaries
Applicant Information
Research Agenda
Our Research Program
Research Webcast
Chapter Grants
Lee C. Howley Sr. Prize for Arthritis Research
Research Conference Summaries
Message Boards
RA Connect
 


Introduction

Learning How glucosamine works

Advances in bone biology may lead to improved RA therapy

Promoting better surgical outcomes

Mortality increased in older women with RA

Scleroderma and kidney disease

Progress in lupus genetics

Contact Us

Sign Up

Archives


Learning how glucosamine works

What is the problem and what is already known?
Glucosamine is a dietary supplement used alone or in combination with chondroitin sulfate to reduce pain in osteoarthritis (OA). In addition, recent studies suggest that it may be a “disease-modifying” agent for OA, i.e., one that can prevent or treat cartilage breakdown and delay the onset of OA. Exactly how glucosamine works isn’t known.  It has been suggested that glucosamine may increase the production of a key type of protein found in cartilage, called proteoglycan, and as a result help to build or repair cartilage. More studies are needed to better understand the mechanism of action of glucosamine, and in particular its effects on cartilage.

Researcher funded by the Arthritis Foundation who was involved in the study: Theodore Oegema, PhD, Rush Medical College, Chicago.

Who was studied and what was done?
Young, growing rabbits with normal knees were compared to rabbits with a recently-damaged knee joint. All were fed glucosamine in a dose comparable to the recommended human dose. After eight weeks the rabbits were examined to determine the effects on their knee cartilage.

What were the study results?
Glucosamine did not affect the rabbits with normal knees, but did increase the amount of proteoglycan content in the cartilage in both the damaged joint and the opposite joint in the experimental animals.

What’s the relevance to people with arthritis?
This type of research is helping to provide the scientific rationale for using glucosamine in people with OA, and will help to clarify when the use of this supplement is warranted.

Source: Arthritis and Rheumatism, September 2002
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12355498&dopt=Abstract

 

 

Research Update is compiled by Michele Boutaugh, BSN, MPH, Medical and Scientific Affairs Department, National Office.

EMAIL THIS PAGE